CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 480818-480942 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Characterization of immunorelevant human brain antigens of multiple sclerosis patients by two-dimensional electrophoresis Z.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T88895","span":{"begin":0,"end":124},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T88895","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T32","span":{"begin":0,"end":124},"obj":"Sentence"}],"attributes":[{"subj":"T32","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1601","span":{"begin":41,"end":46},"obj":"Body_part"}],"attributes":[{"id":"A1601","pred":"uberon_id","subj":"T1601","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"subj":"T1601","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3290","span":{"begin":59,"end":77},"obj":"Disease"},{"id":"T78597","span":{"begin":59,"end":77},"obj":"Disease"}],"attributes":[{"id":"A3290","pred":"mondo_id","subj":"T3290","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A62080","pred":"mondo_id","subj":"T78597","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T3290","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T78597","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93eca1","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec939f"},{"id":"CORD-19-PD-UBERON","color":"#93b9ec"},{"id":"CORD-19-PD-MONDO","color":"#d3ec93"}]}]}}